(SLUS) MSCI USA ESG Screened USD - Overview
Etf: Large, Mid-Cap, ESG, USA, Equity
Dividends
| Dividend Yield | 0.86% |
| Yield on Cost 5y | 1.31% |
| Yield CAGR 5y | 5.66% |
| Payout Consistency | 97.2% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.6% |
| Relative Tail Risk | -2.14% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.14 |
| Alpha | -6.74 |
| Character TTM | |
|---|---|
| Beta | 0.238 |
| Beta Downside | 0.476 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.45% |
| CAGR/Max DD | 0.75 |
Description: SLUS MSCI USA ESG Screened USD January 25, 2026
The iShares MSCI USA ESG Screened UCITS ETF USD (Dist) (XETRA: SLUS) tracks the Morningstar US Large-Mid NR USD index, providing exposure to U.S. large-cap and mid-cap equities that meet iShares’ ESG screening criteria.
Key up-to-date metrics (as of 30 Dec 2025, per iShares disclosures):
• Expense ratio ≈ 0.20% (net of fees).
• Assets under management ≈ $4.2 billion, placing it among the top-10 ESG-focused U.S. equity ETFs in Europe.
• Top five holdings: Apple (5.6 %), Microsoft (5.2 %), Amazon (4.8 %), Alphabet (4.5 %) and Johnson & Johnson (3.1 %).
These figures suggest the fund maintains a composition very close to the broader U.S. large-cap blend, while excluding firms with low ESG scores.
Sector drivers relevant to SLUS’s performance:
• Technology remains the dominant sector (~68 % of net assets), reflecting the index’s large-cap tilt.
• Energy exposure is trimmed to ~2 % versus ~5 % in the unfiltered benchmark, indicating the ESG screen’s impact on fossil-fuel exposure.
• Consumer discretionary and health-care each account for roughly 10 % and 9 % of the portfolio, respectively, providing diversification across growth and defensive themes.
Given the fund’s alignment with both broad market returns and ESG considerations, a quantitative factor analysis (e.g., value, momentum, low-volatility) on ValueRay could help you assess whether its risk-adjusted profile matches your investment objectives.
What is the price of SLUS shares?
Over the past week, the price has changed by -0.36%, over one month by -2.21%, over three months by -0.59% and over the past year by -0.12%.
Is SLUS a buy, sell or hold?
What are the forecasts/targets for the SLUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 14.9 | 34.6% |
SLUS Fundamental Data Overview February 04, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 317.5m EUR (317.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 317.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 317.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.79% (E(317.5m)/V(317.5m) * Re(6.79%) + (debt-free company))
Discount Rate = 6.79% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)